Diabetes Treatment Reimagined:
Diabetes casts a significant shadow over the lives of over 34 million Americans, with an alarming 88 million more teetering on the edge of prediabetes. The standard approach to treatment has long revolved around lifestyle adjustments and symptom control. However, these methods merely scratch the surface, failing to confront the true culprit: metabolic breakdown. Physiologic Insulin Resensitization (PIR) reframes our strategy to target this fundamental issue, opening doors to a new era of diabetes care.
FDA Approved and Insurance Covered
RESTORE, REPAIR, and REGENERATE
CoCure/InSolutions is a groundbreaking approach designed to address the primary cause of metabolic disorders instead of only suppressing symptoms.
They use insulin as a hormone rather than a drug.
It’s FDA Cleared AND Covered by Most Major Insurance Carriers.
PIR therapy has a history spanning over 75 years.
It was only in recent years that CoCure/InSolutions, the patent holders of this therapy, successfully integrated the new hardware technology with sophisticated software algorithms. This advancement allows insulin to be administered in microdoses, functioning more like a hormone rather than a traditional drug. By using insulin in a manner that bio-mimics normal glucose metabolism, you can help your patients regulate their bodies once again!